We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS to Fine Drugmakers for Overcharging Under the 340B Discount Program
HHS to Fine Drugmakers for Overcharging Under the 340B Discount Program
Amid concerns of rising pharmaceutical prices, HHS finalized a rule threatening fines against drugmakers that knowingly overcharge hospitals and providers under the 340B drug discount program.